Rivista di formazione e aggiornamento professionale del pediatra e del medico di base, dal 1982 In collaborazione con l'Associazione Culturale Pediatri

Oltre lo specchio

MeBrain

Gli effetti biologici e clinici del placebo

M. Merlo

Febbraio 2018 - pagg. 127 -132

Contenuto riservato

Per leggere l'articolo completo è necessario effettuare il login.

Non sei ancora registrato? Registrati

Per l'acquisto del singolo articolo scrivi a abbonamenti@medicoebambino.com (la mail si prepara da sola con gli estremi dell'articolo); se accedi, la richiesta parte con un click.

Bibliografia

  • 1. Wolf S. The pharmacology of placebos. Pharmacology Rev 1959;11(4):689-704.
  • 2. Beecher HK. The powerful placebo. JAMA 1955;59: 1602-6.
  • 3. Leslie A. Ethics and practice of placebo therapy. Am J Med 1954;16(6):854.
  • 4. Levine JD, Gordon NC, Fields HI. The mechanism of placebo analgesia. Lancet 1978:312(8091):654-7.
  • 5. Ader R, Cohen N. Behaviorally conditioned immunosoppression and murine systemic lupus erithematosus. Science 1982;215(4539):1534-6.
  • 6. Goebel MU, Trebst AE, Steiner J, et al. Behavioral conditioning of immunosoppression is possible in human. FASEB Journal 2002;16:1869-73.
  • 7. Deutsh R. Conditioned hypoglycemia: a mechanism for saccharin-induced sensitivity to insulin in the rat. J Comp Physiol Psychol 1974;86(2):350-8.
  • 8. Rainero I, Valfrè W, Savi L, et al. Neuroendocrine effects of subcutaneous sumatriptan in patients with migraine. J Endocrinol Invest 2001;24(5):310-4.
  • 9. Benedetti F, Pollo A, Lopiano L, Lanotte M, Vighetti S, Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci 2003;23(10):4315-23.
  • 10. Amanzio M, Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid system versus conditioning-activated specific subsystems. J Neurosci 1999;19(1):484-94.
  • 11. Sandler AD, Bodfish JW. Open-label use of placebos in treatment of ADHD: a pilot study. Child Care Health Dev 2008;34(1):104-10.
  • 12. Sandler AD, Glesne CE, Bodfish JW. Conditioned placebo dose reduction: a new treatment in attention-deficit hyperactivity disorder? J Dev Behav Pediatr 2010;31 (5):369-75.
  • 13. Ader R, Mercurio MG, Walton G, et al. Conditioned pharmacotherapeutic effects: a preliminary study. Psychosom Med 2010;72(2):192-7.
  • 14. Rutherford BR, Sneed JR, Tandler JM, Rindskopf D, Peterson BS, Roose SP. Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact. J Am Acad Child Adolesc Psychiatry 2011;50(8):782-95.
  • 15. Weimer K, Gulewitsch MD, Schlarb AA, Schwille-Kiuntke J, Klosterhalfen S, Enck P. Placebo effects in children: a review. Pediatr Res 2013;74(1):96-102.
  • 16. Whalley B, Hyland ME. Placebo by proxy: the effect of parents' beliefs on therapy for children's temper tantrums. J Behav Med 2013;36(4):341-6.
  • 17. Panizon F, Fontana M. Il placebo, 23 anni dopo. Medico e Bambino 2008;27(9):571-7.
  • 18. Sullivan M. Placebos and treatment of pain. Pain Med 2004;5(3):325-6.
  • 19. Rich BA. A placebo for the pain: a medico-legal case analysis. Pain Med 2003;4(4):366-72.
  • 20. Ventura A. Placebo by proxy. Medico e Bambino 2017;36(7):419.
  • 21. Trogen B, Caplan A, Klass P. The ethics of open-label placebos in pediatrics. Pediatrics 2017;140(2).
  • 22. Silber TH. Placebo therapy: the ethical dimension. JAMA 1979;242(3):245-6.
  • 23. Panizon F. Il placebo. Medico e Bambino 1984;3:164-75.
  • 24. Di Blasi Z, Harkness E, Ernst E, Georgiou A, Kleijnen J. Influence of contest effect on health outcomes. A systematic review. Lancet 2001;357(9258):757-62.

Corrispondenza: merlomaria@alice.it